Table 1 Baseline characteristics of all patients
| ALL | HC | CHB | NAFLD | CHB with NAFLD | |
|---|---|---|---|---|---|
| (N = 2768) | (N = 667) | (N = 970) | (N = 878) | (N = 253) | |
| Gender (male) | 1901 (69%) | 440 (66%) |
651 (67%) NSa‡ |
618 (70%) NSab |
192 (76%) *ab, NSc |
| Age (year) | 40.1 (10.9) | 39.3 (9.2) |
39.8 (11.7) NSa |
41.1 (12.0) NSab |
41.0 (10.2) NSac, *b |
| BMI (kg/m2) | 23.8 (3.9) | 21.8 (2.4) |
22.2 (3.1) **a |
26.5 (3.7) **ab |
26.0 (3.7) **ab, *c |
| Waist–hip ratio | 0.85 (0.07) | 0.80 (0.06) |
0.84 (0.07) **a |
0.89 (0.04) **ab |
0.89 (0.05) **ab, NSc |
| SBP (mmHg) | 124.2 (13.1) | 116.2 (12.1) |
124.8 (10.1) **a |
127.7 (14.7) **ab |
130.0 (10.8) **ab, *c |
| DBP (mmHg) | 79.8 (9.9) | 72.1 (9.2) |
82.3 (8.1) **a |
82.4 (9.9) **a, *b |
86.0 (11.1) **ab |
| CHOL (mmol/L) | 5.1 (1.0) | 4.7 (0.6) |
4.9 (1.1) **a |
5.5 (1.1) **ab |
5.2 (1.1) **ab, *c |
| TG (mmol/L) | 1.6 (1.7) | 1.0 (0.5) |
1.3 (0.8) **a |
2.5 (2.5) **ab |
1.7 (1.3) **ab |
| HDL-C (mmol/L) | 1.3 (0.4) | 1.4 (0.2) |
1.3 (0.4) NSa |
1.1 (0.3) **ab |
1.2 (0.4) **ab, NSc |
| LDL-C (mmol/L) | 3.1 (0.9) | 2.9 (0.7) |
3.1 (0.8) **a |
3.3 (0.9) **ab |
3.4 (0.9) **ab, NSc |
| FBG (mmol/L) | 5.0 (0.9) | 4.8 (0.4) |
4.8 (0.7) NSa |
5.4 (1.2) **ab |
5.3 (1.3) **ab, *c |
| FINS (μU/mL) | 8.7 (6.3) | 6.2 (3.4) |
7.3 (4.8) *a |
11.3 (7.4) **ab |
12.0 (7.9) **ab, NSc |
| HOMA-IR | 2.0 (1.8) | 1.3 (0.8) |
1.6 (1.3) *a |
2.7 (2.1) **ab |
2.9 (2.6) **ab, NSc |
| UA (μmol/L) | 358.2 (102.4) | 309.1 (89.0) |
339.0 (92.2) **a |
402.8 (102.2) **ab |
401.9 (93.2) **ab, NSc |
| ALT (U/L) | 45.9 (63.5) | 20.1 (10.9) |
55.1 (90.9) **a |
51.4 (44.4) **ab |
61.5 (64.5) **ab,*c |
| AST (U/L) | 37.1 (49.0) | 24.4 (6.0) |
44.2 (75.4) **a |
37.3 (26.2) **a, *b |
44.0 (43.1) **a, *bc |
| ALB (g/L) | 45.6 (3.2) | 46.5 (0.2) |
44.9 (4.1) **a |
45.97 (2.8) **ab |
45.2 (3.8) **ac, *b |
| TB (μmol/L) | 14.6 (5.3) | 13.6 (0.2) |
15.2 (6.8) *a |
14.46 (5.1) **a, NSb |
14.5 (6.2) *a, NSbc |